wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57265716-5087FDFC-4F59-422D-ADEE-AFE59C61BACA
Q57265716-5087FDFC-4F59-422D-ADEE-AFE59C61BACA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57265716-5087FDFC-4F59-422D-ADEE-AFE59C61BACA
Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial†
P2860
Q57265716-5087FDFC-4F59-422D-ADEE-AFE59C61BACA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57265716-5087FDFC-4F59-422D-ADEE-AFE59C61BACA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7221ed5ab0dcbd565f617881c9fe0dbd23d968fd
P2860
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Gr